EUVIMED · CrossrefJournal
Drugs
ISSN 0012-6667 · Springer Science and Business Media LLC
Latest articles
The Pharmacological Basis of SGLT2 Inhibitor-Mediated Kidney Protection: From Proximal Tubular Mechanisms to Clinical Outcomes
Oveporexton: First Approval
Daraxonrasib: First Approval
Insulin Efsitora Alfa: First Approval
Enlicitide: First Approval
Iberdomide: First Approval
Acknowledgement to Referees
Advances in Attribution and Management of NPSLE Manifestations of Lupus: Current Paradigms and Emerging Evidence
Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors: A State-of-the-Art Narrative Review
Vepdegestrant: First Approval
Efficacy and Safety of IGF-1 Receptor Inhibitors for Thyroid Eye Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials
PSMA Biology Through the Clinical Lens: Implications for Radioligand Therapy of Prostate Cancer with [177Lu]Lu-PSMA-617
Comparative Effects of Pharmacological Treatment on Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
Twelve-Month Cumulative Incidence, Characteristics, and Correlates of Non-adherence in Youths Treated with Second-Generation Antipsychotics for Mental Disorders: Results from a Prospective Cohort Study
Rocbrutinib: First Approval
GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis
Cefepime/Zidebactam: First Approval
Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2– Advanced Breast Cancer
Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions
Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus
Sex-Biased Pharmacotherapeutic Disparities in Hypertension
Correction: Plozasiran: First Approval
Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases
Emerging Cardiorenal Protective Therapies in Lupus Nephritis
Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians
Misuse of Pregabalin and Gabapentin: A Second Systematic Review Update
Recaticimab: The First Fc-Engineered PCSK9 Monoclonal Antibody for More Long-Lasting Effect in Lipid Lowering
Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews
Efficacy and Safety of SPH3127 Tablet, a Novel Direct Renin Inhibitor, in Patients with Mild-to-Moderate Essential Hypertension: A Phase III Randomised Trial
Lerodalcibep: First Approval
Volumes
2026 · 1662025 · 1332024 · 1422023 · 1542022 · 1682021 · 2072020 · 1932019 · 2022018 · 1802017 · 1732016 · 1602015 · 1772014 · 1712013 · 1532012 · 1732011 · 1502010 · 1582009 · 1682008 · 1782007 · 2162006 · 2632005 · 2142004 · 2382003 · 2212002 · 2202001 · 1852000 · 2001999 · 3861998 · 2071997 · 2281996 · 2301995 · 2991994 · 1861993 · 4611992 · 2141991 · 2081990 · 2421989 · 1691988 · 3901987 · 286
EUVIMED